We searched the Cochrane Library, PubMed, and Embase for papers published between 2008 and 2012 with the terms “COPD and comorbidities”, “COPD and cardiovascular disease”, “COPD and lung cancer”, “COPD and osteoporosis”, “COPD and muscle weakness”, “COPD and statins”, “COPD and angiotensin II converting enzyme inhibitors”, “COPD and angiotensin receptor blockers”, and “lung cancer and statins”. We also searched the reference lists of identified articles for further relevant papers, and we
ReviewChronic obstructive pulmonary disease and comorbidities
Introduction
Chronic obstructive pulmonary disease (COPD) is a progressive debilitating disease with high prevalence. It is the fourth most prevalent cause of death and is responsible for very high expenditures in the health-care system. Global economic costs generated by COPD amount to US$2·1 trillion and are expected to increase to $4·8 trillion by 2030.1 A considerable proportion of these costs is due to the fact that this is a complex disease associated with several serious comorbidities.2
Many comorbidities are associated with COPD, and those for which there are the most data include cardiovascular and cerebrovascular disease, lung cancer, diabetes, muscle weakness, osteoporosis, and anxiety and depression. A randomly selected sample of 1522 patients who were enrolled in a health maintenance organisation in 1997, had on average 3·7 comorbid disorders compared with 1·8 in controls.3 These comorbidities contribute substantially to reduced health status, increased health-care utilisation, all-cause hospital admission, and mortality.4, 5 In fact, patients with COPD are more likely to die from comorbidities than from the disease itself. In a well-designed study in which a panel of senior physicians critically studied and adjudicated the causes of death in patients with COPD, only 40% of deaths were definitely or probably related to COPD, whereas 50% were unrelated to COPD, and 9% were unknown.6 A third of the deaths were due to cardiovascular disease.
We will briefly review the evidence for a link between COPD and the major comorbidities of the disease, with a focus on the mechanisms of their association with COPD, and discuss the implications of these links to the treatment of COPD. We only address the major comorbidities, for which mechanistic links with COPD have recently been studied.
Section snippets
Cardiovascular disease
Cardiovascular disease is not a clearly defined disorder. It usually encompasses ischaemic heart disease, congestive heart failure, pulmonary vascular disease, coronary artery disease, peripheral vascular disease, and stroke and transient ischaemic attack. It might also include biomarkers of disease such as lipid abnormalities or inflammatory markers of disease. This section will mainly focus on ischaemic heart disease, because recent mechanistic work has focused on this area.
The association of
Lung cancer
COPD is an independent risk factor for the development of lung cancer and is associated with a lung cancer risk that is two to six times that of smokers without COPD.34, 35, 36, 37, 38 Reduced FEV1 was shown to increase the risk of incident lung cancer independently of smoking history.37 Moreover, COPD was associated with lung cancer in never-smokers;36 hence, the association is not solely due to smoking. Airflow obstruction and emphysema were also shown to be independent risk factors for lung
Osteoporosis, muscle weakness, and cachexia
A third group of comorbidities includes muscle, fat, and bone wasting (figure 5). These changes in body composition cluster together and associate with emphysema or so-called wasting of the lung.66 Sin and colleagues67 used the data from NHANES III to show that airflow obstruction was independently associated with reduced bone mineral density. Prevalence of osteoporosis increased as the severity of airflow obstruction increased. In women with severe COPD, 33% had osteoporosis and nearly all had
Comorbidity and ageing
Ageing is associated with an increased incidence of non-communicable diseases including cardiovascular disease, type 2 diabetes, osteoporosis, cancer, and COPD.94 The cellular equivalent to physiological ageing is senescence.95 Replicative senescence refers to telomere shortening, which, at a specific length, induces stress signals that lead to cell cycle arrest. However, external stressors such as oxidative stress might also induce premature senescence. One implication of senescence is that
Treatment of comorbidities
Comorbidities should be detected in the medical follow-up scheme for patients with COPD, but no clear guidelines on how and when to screen for comorbidities are available. To the best of our knowledge, specific randomised controlled studies into the treatment of comorbidities in patients prospectively identified as having COPD have not yet been done. Nevertheless, common sense suggests that comorbidities should be treated in patients with COPD with proven treatment regimens. Detection and
Search strategy and selection criteria
References (131)
- et al.
The global economic burden of non-communicable diseases: a report by the World Economic Forum and the Harvard School of Public Health, September 2011
(2011) - et al.
COPD as a lung disease with systemic consequences—clinical impact, mechanisms, and potential for early intervention
COPD
(2008) - et al.
Health care utilization in chronic obstructive pulmonary disease: a case-control study in a health maintenance organization
Arch Intern Med
(2000) - et al.
Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease
Am J Respir Crit Care Med
(2012) - et al.
Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art
Expert Rev Respir Med
(2011) - et al.
Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee
Thorax
(2007) - et al.
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD
Eur Respir J
(2008) - et al.
Causes of death in patients with COPD and chronic respiratory failure
Monaldi Arch Chest Dis
(1997) - et al.
Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study
Respir Med
(2006) - et al.
Mortality in COPD: role of comorbidities
Eur Respir J
(2006)
The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature
Chest
Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care
Thorax
Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk
Thorax
Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease
Am J Respir Crit Care Med
Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD
Am J Med
Prevalence of comorbidities in patients with chronic obstructive pulmonary disease
Respiration
Myocardial infarction and other co-morbidities in patients with chronic obstructive pulmonary disease: a Danish nationwide study of 7·4 million individuals
Eur Heart J
Pulmonary function in diabetes: a meta-analysis
Chest
International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study
Lancet
Lung cancer and cardiovascular disease mortality associated with ambient air pollution and cigarette smoke: shape of the exposure-response relationships
Environ Health Perspect
The nature of small-airway obstruction in chronic obstructive pulmonary disease
N Engl J Med
Particulate air pollution induces progression of atherosclerosis
J Am Coll Cardiol
Cigarette smoking causes sequestration of polymorphonuclear leukocytes released from the bone marrow in lung microvessels
Am J Respir Cell Mol Biol
Vulnerable plaque: pathobiology and clinical implications
Ann Intern Med
Widespread coronary inflammation in unstable angina
N Engl J Med
The relationship between lung inflammation and cardiovascular disease
Am J Respir Crit Care Med
Risk of myocardial infarction and stroke after acute infection or vaccination
N Engl J Med
Increased risk of myocardial infarction and stroke following exacerbation of COPD
Chest
Possible mechanisms of the cardiovascular effects of inhaled particles: systemic translocation and prothrombotic effects
Toxicol Lett
Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study
Am J Respir Crit Care Med
Lung function impairment and metabolic syndrome: the critical role of abdominal obesity
Am J Respir Crit Care Med
Cardiac disease in chronic obstructive pulmonary disease
Proc Am Thorac Soc
Cardiovascular mechanisms of death in severe COPD exacerbation: time to think and act beyond guidelines
Thorax
Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest
Chest
Low lung function and incident lung cancer in the United States: data from the first National Health and Nutrition Examination Survey follow-up
Arch Intern Med
Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers
Am J Respir Crit Care Med
Association of radiographic emphysema and airflow obstruction with lung cancer
Am J Respir Crit Care Med
COPD prevalence is increased in lung cancer, independent of age, sex and smoking history
Eur Respir J
The effects of a smoking cessation intervention on 14·5-year mortality: a randomized clinical trial
Ann Intern Med
Lung cancer in patients with chronic obstructive pulmonary disease—incidence and predicting factors
Am J Respir Crit Care Med
Effects of cigarette smoke on the human airway epithelial cell transcriptome
Proc Natl Acad Sci USA
Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship
Mayo Clin Proc
A translational view of the molecular pathogenesis of lung cancer
J Thorac Oncol
Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer
Nat Med
Emerging evidence of epithelial-to-mesenchymal transition in lung carcinogenesis
Respirology
A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci
PLoS Genet
Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium
J Natl Cancer Inst
The TERT-CLPTM1L locus for lung cancer predisposes to bronchial obstruction and emphysema
Eur Respir J
Chromosome 4q31 locus in COPD is also associated with lung cancer
Eur Respir J
Individual and cumulative effects of GWAS susceptibility loci in lung cancer: associations after sub-phenotyping for COPD
PLoS One
Cited by (219)
COPD and multimorbidity: recognising and addressing a syndemic occurrence
2023, The Lancet Respiratory MedicineThe causal relationship between psoriasis and chronic obstructive pulmonary disease: A bidirectional mendelian randomization study
2024, Skin Research and TechnologyComorbidities in COPD: Current and Future Treatment Challenges
2024, Journal of Clinical Medicine